Fingerprint
Dive into the research topics of 'Cetuximab is associated with excessive toxicity when combined with bevacizumab plus mFOLFOX6 in metastatic colorectal carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Cetuximab is associated with excessive toxicity when combined with bevacizumab plus mFOLFOX6 in metastatic colorectal carcinoma
Allyson J. Ocean, Blase Polite, Paul Christos, Lisa Horvath, Anne Hamilton, Daniel Matulich, Helen X. Chen, Joseph A. Sparano, Hedy L. Kindler
Research output: Contribution to journal › Article › peer-review
8
Scopus
citations